BIA 28-6156
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BIA 28-6156, covering 2025-05-28 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Compassionate Use for BIA 28-6156 in Patients With Parkinson's Disease (PD) Who Have a Pathogenic Variant in the GBA1 Gene (GBA-PD) and Completed the ACTIVATE Study